Fierce Healthcare
JANUARY 7, 2022
CMS issued over 300 warnings, but no fines, to hospitals falling short on price transparency last year. dmuoio. Fri, 01/07/2022 - 17:39.
pharmaphorum
JANUARY 7, 2022
AstraZeneca has clearly made the rare disease transthyretin amyloidosis (ATTR) a key component of its rare disease pipeline, licensing a second drug candidate in the space of a couple of months. In the latest deal, the pharma group is paying $30 million upfront with another $730 million in milestone’s for global rights to Neurimmune’s NI006, a drug in early-stage clinical for cardiomyopathy, a progressive and fatal complication affecting some patients with ATTR.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Healthcare
JANUARY 7, 2022
Healthcare smashed venture funding records in 2021 despite poor market performance. rtorrence. Fri, 01/07/2022 - 11:34.
pharmaphorum
JANUARY 7, 2022
Kidney cancer is the 14 th most common cancer, with approximately 400,000 new cases worldwide every year. Renal cell carcinoma (RCC) is by far the most prevalent type of cancer originating from the kidney, making up nine out of ten kidney cancer diagnoses. As chief medical officer, head of global medical affairs, patient safety and patient affairs – putting patient interests first is central to my role and values.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Fierce Healthcare
JANUARY 7, 2022
Justices appear likely to narrowly uphold CMS vaccine mandate on hold in half of US. rking. Fri, 01/07/2022 - 15:44.
pharmaphorum
JANUARY 7, 2022
If the last couple of days is an indication, 2022 is already shaping up to be the year of big-ticket alliances between big pharma companies and specialists in artificial intelligence-driven discovery. Shortly after Amgen unveiled its $1.9 billion alliance with Generate Biomedicines aimed initially at five drug molecules, Sanofi has announced a big expansion of its longstanding partnership with Exscientia that covers no fewer than 15 programmes.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Turnkey Pharmacy Solutions
JANUARY 7, 2022
When I was young, I remember my dad saying time and time again, “knowledge is power.” He was always on a quest to learn and to know why or how things worked. It was then, as he felt, his duty to educate my sisters and me. He would end his tutorial with “And now you.
Fierce Healthcare
JANUARY 7, 2022
Eying a 'new normal,' former Biden health advisors call for sweeping pandemic policy changes. dmuoio. Fri, 01/07/2022 - 12:03.
The Physician Pharmacist
JANUARY 7, 2022
As a pharmacy student interested in a career in medicine, it's imperative that you have an appreciation for the medical school application cycle timeline! It's already hard balancing your pharmacy school obligations, so don't make it harder on yourself by skipping over this crucial timeline! If you know what's on the horizon, you can chart your journey and navigate your application to the promised land!
Fierce Healthcare
JANUARY 7, 2022
Key industry partners funnel Medically Home another $110M to deliver acute care at home. dmuoio. Fri, 01/07/2022 - 16:29.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharma Tutor
JANUARY 7, 2022
Durian - the King of fruits for health. Manisha Choudhary 1 , Rajesh Vagh 2 , MM Abid Ali Khan 3 , Raaz K. Maheshwari* 4. admin. Sat, 01/08/2022 - 11:09. Tags. Articles.
Fierce Healthcare
JANUARY 7, 2022
Industry Voices—The case against excluding specialty coverage. pminemyer. Fri, 01/07/2022 - 12:01.
Pharma Times
JANUARY 7, 2022
The platform integrates primary human tissue samples into early target and drug discovery research.
pharmaphorum
JANUARY 7, 2022
It’s no secret that fertility treatment is expensive and has a low success rate, placing a big financial and emotional burden on would-be parents. Now, a Canadian startup aims to tackle that problem though the use of artificial intelligence. Toronto-based Future Fertility has developed an AI called Violet that it says can predict the viability of cryopreserved eggs used for in vitro fertilisation (IVF), making sure that those most likely to result in a successful procedure.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharma Times
JANUARY 7, 2022
With over 48,000 new cases diagnosed per year, lung cancer is the third most common cancer in the UK.
Expert insights. Personalized for you.
138 
Let's personalize your content